Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 206

1.

α-Lipoic acid interaction with dopamine D2 receptor-dependent activation of the Akt/GSK-3β signaling pathway induced by antipsychotics: potential relevance for the treatment of schizophrenia.

Deslauriers J, Desmarais C, Sarret P, Grignon S.

J Mol Neurosci. 2013 May;50(1):134-45. doi: 10.1007/s12031-012-9884-4. Epub 2012 Sep 14.

PMID:
22975849
2.

Implication of the ERK/MAPK pathway in antipsychotics-induced dopamine D2 receptor upregulation and in the preventive effects of (±)-α-lipoic acid in SH-SY5Y neuroblastoma cells.

Deslauriers J, Desmarais C, Sarret P, Grignon S.

J Mol Neurosci. 2014 Mar;52(3):378-83. doi: 10.1007/s12031-013-0158-6. Epub 2013 Nov 8.

PMID:
24203573
3.

Kainic acid-induced seizures modulate Akt (SER473) phosphorylation in the hippocampus of dopamine D2 receptor knockout mice.

Dunleavy M, Provenzano G, Henshall DC, Bozzi Y.

J Mol Neurosci. 2013 Jan;49(1):202-10. doi: 10.1007/s12031-012-9927-x. Epub 2012 Nov 29.

4.

Differential effects of amisulpride and haloperidol on dopamine D2 receptor-mediated signaling in SH-SY5Y cells.

Park SW, Seo MK, Cho HY, Lee JG, Lee BJ, Seol W, Kim YH.

Neuropharmacology. 2011 Sep;61(4):761-9. doi: 10.1016/j.neuropharm.2011.05.022. Epub 2011 Jun 2.

PMID:
21663752
5.

Differential modulation of Akt/glycogen synthase kinase-3beta pathway regulates apoptotic and cytoprotective signaling responses.

Nair VD, Olanow CW.

J Biol Chem. 2008 May 30;283(22):15469-78. doi: 10.1074/jbc.M707238200. Epub 2008 Apr 3.

6.

Possible involvement of post-dopamine D2 receptor signalling components in the pathophysiology of schizophrenia.

Amar S, Shaltiel G, Mann L, Shamir A, Dean B, Scarr E, Bersudsky Y, Belmaker RH, Agam G.

Int J Neuropsychopharmacol. 2008 Mar;11(2):197-205. Epub 2007 Aug 6.

PMID:
17681085
7.

The effects of neuropsychiatric drugs on glycogen synthase kinase-3 signaling.

Sutton LP, Rushlow WJ.

Neuroscience. 2011 Dec 29;199:116-24. doi: 10.1016/j.neuroscience.2011.09.056. Epub 2011 Oct 4.

PMID:
22001305
8.

Early effects of mood stabilizers on the Akt/GSK-3beta signaling pathway and on cell survival and proliferation.

Aubry JM, Schwald M, Ballmann E, Karege F.

Psychopharmacology (Berl). 2009 Aug;205(3):419-29. doi: 10.1007/s00213-009-1551-2. Epub 2009 May 14.

PMID:
19440698
9.

Signaling pathways leading to phosphorylation of Akt and GSK-3β by activation of cloned human and rat cerebral D₂and D₃ receptors.

Mannoury la Cour C, Salles MJ, Pasteau V, Millan MJ.

Mol Pharmacol. 2011 Jan;79(1):91-105. doi: 10.1124/mol.110.065409. Epub 2010 Oct 15.

PMID:
20952497
10.

Transient and rapid activation of Akt/GSK-3β and mTORC1 signaling by D3 dopamine receptor stimulation in dorsal striatum and nucleus accumbens.

Salles MJ, Hervé D, Rivet JM, Longueville S, Millan MJ, Girault JA, Mannoury la Cour C.

J Neurochem. 2013 May;125(4):532-44. doi: 10.1111/jnc.12206. Epub 2013 Mar 11.

11.

Antipsychotic-induced DRD2 upregulation and its prevention by α-lipoic acid in SH-SY5Y neuroblastoma cells.

Deslauriers J, Lefrançois M, Larouche A, Sarret P, Grignon S.

Synapse. 2011 Apr;65(4):321-31. doi: 10.1002/syn.20851. Epub 2010 Sep 24.

PMID:
20730801
12.

Antagonism of dopamine D2 receptor/beta-arrestin 2 interaction is a common property of clinically effective antipsychotics.

Masri B, Salahpour A, Didriksen M, Ghisi V, Beaulieu JM, Gainetdinov RR, Caron MG.

Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13656-61. doi: 10.1073/pnas.0803522105. Epub 2008 Sep 3.

13.

Protective effects of olanzapine and haloperidol on serum withdrawal-induced apoptosis in SH-SY5Y cells.

Kim NR, Park SW, Lee JG, Kim YH.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 1;32(3):633-42. Epub 2007 Nov 12.

PMID:
18055082
14.

DRD2/AKT1 interaction on D2 c-AMP independent signaling, attentional processing, and response to olanzapine treatment in schizophrenia.

Blasi G, Napolitano F, Ursini G, Taurisano P, Romano R, Caforio G, Fazio L, Gelao B, Di Giorgio A, Iacovelli L, Sinibaldi L, Popolizio T, Usiello A, Bertolino A.

Proc Natl Acad Sci U S A. 2011 Jan 18;108(3):1158-63. doi: 10.1073/pnas.1013535108. Epub 2010 Dec 27.

15.

(R)-(+)-α-lipoic acid protected NG108-15 cells against H₂O₂-induced cell death through PI3K-Akt/GSK-3β pathway and suppression of NF-κβ-cytokines.

Kamarudin MN, Mohd Raflee NA, Hussein SS, Lo JY, Supriady H, Abdul Kadir H.

Drug Des Devel Ther. 2014 Oct 8;8:1765-80. doi: 10.2147/DDDT.S67980. eCollection 2014.

16.

Deletion of GSK3β in D2R-expressing neurons reveals distinct roles for β-arrestin signaling in antipsychotic and lithium action.

Urs NM, Snyder JC, Jacobsen JP, Peterson SM, Caron MG.

Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):20732-7. doi: 10.1073/pnas.1215489109. Epub 2012 Nov 27.

17.

Kainic acid-induced seizures activate GSK-3β in the hippocampus of D2R-/- mice.

Tripathi PP, Santorufo G, Brilli E, Borrelli E, Bozzi Y.

Neuroreport. 2010 Aug 23;21(12):846-50. doi: 10.1097/WNR.0b013e32833d5891.

PMID:
20625330
18.

Beta-arrestin-1 mediates the endothelin-1-induced activation of Akt and integrin-linked kinase.

Cianfrocca R, Rosanò L, Spinella F, Di Castro V, Natali PG, Bagnato A.

Can J Physiol Pharmacol. 2010 Aug;88(8):796-801. doi: 10.1139/Y10-052.

19.

The Akt-GSK-3 signaling cascade in the actions of dopamine.

Beaulieu JM, Gainetdinov RR, Caron MG.

Trends Pharmacol Sci. 2007 Apr;28(4):166-72. Epub 2007 Mar 8. Review.

PMID:
17349698
20.

Inhibition of GSK-3beta promotes survival and proliferation of megakaryocytic cells through a beta-catenin-independent pathway.

Soda M, Willert K, Kaushansky K, Geddis AE.

Cell Signal. 2008 Dec;20(12):2317-23. doi: 10.1016/j.cellsig.2008.09.001. Epub 2008 Sep 6.

Supplemental Content

Support Center